Clinical Trial Update: Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line [Phase 3]

View source ↗

Summary

Phase 3 trial update on MT10107 for treatment of glabellar frown lines, reporting efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• MT10107

Snippet

Sponsor: Medy-Tox | Conditions: Glabellar Frown Lines | Phase 3 | Status: COMPLETED